JOSÉ ANTONIO
LORENTE ACOSTA
CATEDRÁTICO DE UNIVERSIDAD
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (6)
2015
-
Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels
Prostate, Vol. 75, Núm. 11, pp. 1216-1226
-
Combined analysis of copy number alterations by single-nucleotide polymorphism array and MYC status in non-metastatic breast cancer patients: comparison according to the circulating tumor cell status
Tumor Biology, Vol. 36, Núm. 2, pp. 711-718
2014
-
EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
Oncotarget, Vol. 5, Núm. 17, pp. 7486-7497
2013
-
CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy
International Journal of Cancer, Vol. 133, Núm. 10, pp. 2398-2407
2012
-
Biomarkers characterization of circulating tumour cells in breast cancer patients
Breast Cancer Research, Vol. 14, Núm. 3
1999
-
Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients
European Journal of Nuclear Medicine, Vol. 26, Núm. 6, pp. 625-632